Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection
Highlights • Administration of attenuated Salmonella harbouring the VapA antigen (STM VapA+) via nasal route induced a protective immune response. • STM VapA+ protects TLR2-KO and TLR4-deficient mice against R. equi challenge. • STM VapA+ stimulates antigen-specific CD4+ T cells without the particip...
Saved in:
Published in: | Vaccine Vol. 31; no. 41; pp. 4528 - 4535 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Kidlington
Elsevier Ltd
23-09-2013
Elsevier Elsevier Limited |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights • Administration of attenuated Salmonella harbouring the VapA antigen (STM VapA+) via nasal route induced a protective immune response. • STM VapA+ protects TLR2-KO and TLR4-deficient mice against R. equi challenge. • STM VapA+ stimulates antigen-specific CD4+ T cells without the participation of TLR2. • TLR2 is required for immune response recall in a mouse model. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.vaccine.2013.07.067 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2013.07.067 |